
Chiesi unveils €430M investment to revitalize Italian production site for inhaler, biologics manufacturing
A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly half-a-billion-dollar investment from Italian drugmaker Chiesi. As part of an ongoing expansion strategy around the globe, Chiesi announced …